Search Within

Martin Fleisher

Formats
  1. Journal Article (161)
  2. Meeting Abstract (140)
  3. Book Section (6)
  4. Conference Paper (4)
  5. Book Whole (1)
Groups
  1. Department of Medicine (180)
  2. Solid Tumor Oncology Division (113)
  3. Genitourinary Oncology Service (81)
  4. Epidemiology and Biostatistics (77)
  5. Hematologic Malignancies, Division of (67)
  6. Biostatistics Service (64)

More Groups

People
  1. Howard Scher (78)
  2. Daniel Danila (48)
  3. Raymond Comenzo (36)
  4. Aseem Anand (34)
  5. Glenn Heller (32)
  6. Ping Zhou (30)

More People

Years
  1. 2024 (3)
  2. 2023 (1)
  3. 2022 (3)
  4. 2021 (1)
  5. 2020 (5)
  6. 2019 (4)

More Years

Publications
  1. Journal of Clinical Oncology (59)
  2. Clinical Chemistry (32)
  3. Blood (26)
  4. Clinical Cancer Research (10)
  5. Cancer Research (9)
  6. Neuro-Oncology (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (60)
  2. American Association for Clinical Chemistry (32)
  3. American Association for Cancer Research (26)
  4. American Society of Hematology (26)
  5. Oxford University Press (19)
  6. Elsevier Inc. (16)

More Publishers

Results (312)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized, double-blind, phase II study of temozolomide in combination with either veliparib or placebo in patients with relapsed-sensitive or refractory small-cell lung cancer
    Journal Article

    Pietanza, M. C.; Waqar, S. N.; Krug, L. M.; Dowlati, A.; Hann, C. L.; Chiappori, A.; Owonikoko, T. K.; Woo, K. M.; Cardnell, R. J.; Fujimoto, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Assessment of the validity of nuclear-localized androgen receptor splice variant 7 in circulating tumor cells as a predictive biomarker for castration-resistant prostate cancer
    Journal Article

    Scher, H. I.; Graf, R. P.; Schreiber, N. A.; Jayaram, A.; Winquist, E.; McLaughlin, B.; Lu, D.; Fleisher, M.; Orr, S.; Lowes, L.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Reply to C. Ren et al
    Journal Article

    Heller, G.; McCormack, R.; Kheoh, T.; Molina, A.; Smith, M. R.; Dreicer, R.; Saad, F.; de Wit, R.; Aftab, D. T.; Hirmand, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Procalcitonin and cytokine levels in cancer patients with neutropenia and bloodstream infections
    Meeting Abstract

    Blouin, A.; Pastores, S.; Halpern, N.; Fleisher, M.; Ramanathan, L.
    Critical Care Medicine (2018)

    Fulltext@MSK | Save
  • Current and emerging multianalyte assays with algorithmic analyses - Are laboratories ready for clinical adoption?
    Journal Article

    ColoĢn-Franco, J. M.; Bossuyt, P. M. M.; Algeciras-Schimnich, A.; Bird, C.; Engstrom-Melnyk, J.; Fleisher, M.; Kattan, M.; Lambert-Messerlian, G.
    Clinical Chemistry (2018)

    Fulltext@MSK | Save
  • Relevance of serum chromogranin A as diagnostic and prognostic marker for well-differentiated pancreatic neuroendocrine tumors
    Meeting Abstract

    Pulvirenti, A.; Rao, D.; Tang, L.; Gonen, M.; Fleisher, M.; Reidy-Lagunes, D.; Allen, P.
    Pancreas (2018)

    Fulltext@MSK | Save
  • Circulating tumor cell number as a response measure of prolonged survival for metastatic castration-resistant prostate cancer: A comparison with prostate-specific antigen across five randomized phase III clinical trials
    Journal Article

    Heller, G.; McCormack, R.; Kheoh, T.; Molina, A.; Smith, M. R.; Dreicer, R.; Saad, F.; de Wit, R.; Aftab, D. T.; Hirmand, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Elevated alkaline phosphatase in a cancer patient: Think you know the source?
    Journal Article

    Carroll, B. L.; Fleisher, M.; Pessin, M. S.; Ramanathan, L. V.
    Journal of Applied Laboratory Medicine (2017)

    Fulltext@MSK | Save
  • Unexpected interference on Alere Triage B-type natriuretic peptide measurement
    Journal Article

    Tecleab, A.; Miller, L.; Brewster, A.; Fleisher, M.; Ramanathan, L.
    Journal of Applied Laboratory Medicine (2017)

    Fulltext@MSK | Save
  • Baseline CTC subtype to predict outcomes on mCRPC patients (pts) receiving enzalutamide (E) compared to abiraterone (A)
    Meeting Abstract

    Scher, H. I.; Jendrisak, A.; Schreiber, N. A.; McLaughlin, B.; Graf, R. P.; Rodriguez, A.; Fleisher, M.; Lee, J.; Kelvin, J.; Wang, Y.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save